Skip to main content
Clinical Trials/JPRN-UMIN000049672
JPRN-UMIN000049672
Completed
N/A

Study of the effect on cognitive function by continuous intake of polyamine - Study of the effect on cognitive function by continuous intake of polyamine

Healthcare Systems Co., Ltd.0 sites54 target enrollmentDecember 2, 2022
ConditionsHealthy Adults

Overview

Phase
N/A
Intervention
Not specified
Conditions
Healthy Adults
Sponsor
Healthcare Systems Co., Ltd.
Enrollment
54
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 2, 2022
End Date
July 31, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Persons who have chronic illness, receiving medication, have a serious disease history 2\.Patients suffering from cancer, familial colorectal adenomatosis, or H. pylori infection. 3\.Persons who have any allergies to the ingredients used in the test food (especially persons who have allergies to wheat) 4\.Persons who regularly take of polyamine\-containing supplements 5\.Persons who consume at least one pack of natto every day. 6\.Persons who consume at least one pack of soy milk (approximately200ml) every day. 7\.Persons who regularly use medicines or foods with health claims (foods for specified health use, foods with functional claims and foods with nutritional claims) etc., that may affect cognitive function. 8\.Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam 9\.Persons who were judged as inappropriate for study participants by the principal investigator 10\.Persons who are pregnant, planning or hoping to be pregnant during the study period, breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials